{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:08Z","timestamp":1787065328691,"version":"build-2736575974"},"reference-count":118,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000125","name":"National Institute for Occupational Safety and Health","doi-asserted-by":"publisher","award":["U24OH009077"],"award-info":[{"award-number":["U24OH009077"]}],"id":[{"id":"10.13039\/100000125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH094564"],"award-info":[{"award-number":["R01MH094564"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is an aggressive cancer affecting the outer lining of the lung, with a median survival of less than one year. We constructed an \u2018MPM interactome\u2019 with over 300 computationally predicted protein-protein interactions (PPIs) and over 2400 known PPIs of 62 literature-curated genes whose activity affects MPM. Known PPIs of the 62 MPM associated genes were derived from Biological General Repository for Interaction Datasets (BioGRID) and Human Protein Reference Database (HPRD). Novel PPIs were predicted by applying the HiPPIP algorithm, which computes features of protein pairs such as cellular localization, molecular function, biological process membership, genomic location of the gene, and gene expression in microarray experiments, and classifies the pairwise features as interacting or non-interacting based on a random forest model. We validated five novel predicted PPIs experimentally. The interactome is significantly enriched with genes differentially ex-pressed in MPM tumors compared with normal pleura and with other thoracic tumors, genes whose high expression has been correlated with unfavorable prognosis in lung cancer, genes differentially expressed on crocidolite exposure, and exosome-derived proteins identified from malignant mesothelioma cell lines. 28 of the interactors of MPM proteins are targets of 147 U.S. Food and Drug Administration (FDA)-approved drugs. By comparing disease-associated versus drug-induced differential expression profiles, we identified five potentially repurposable drugs, namely cabazitaxel, primaquine, pyrimethamine, trimethoprim and gliclazide. Preclinical studies may be con-ducted in vitro to validate these computational results. Interactome analysis of disease-associated genes is a powerful approach with high translational impact. It shows how MPM-associated genes identified by various high throughput studies are functionally linked, leading to clinically translatable results such as repurposed drugs. The PPIs are made available on a webserver with interactive user interface, visualization and advanced search capabilities.<\/jats:p>","DOI":"10.3390\/cancers13071660","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T10:44:01Z","timestamp":1617273841000},"page":"1660","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions"],"prefix":"10.3390","volume":"13","author":[{"given":"Kalyani B.","family":"Karunakaran","sequence":"first","affiliation":[{"name":"Supercomputer Education and Research Centre, Indian Institute of Science, Bangalore 560012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Yanamala","sequence":"additional","affiliation":[{"name":"Exposure Assessment Branch, National Institute of Occupational Safety and Health, Center for Disease Control, Morgantown, WV 26506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Boyce","sequence":"additional","affiliation":[{"name":"Exposure Assessment Branch, National Institute of Occupational Safety and Health, Center for Disease Control, Morgantown, WV 26506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Becich","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-0924","authenticated-orcid":false,"given":"Madhavi K.","family":"Ganapathiraju","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA"},{"name":"Intelligent Systems Program, School of Computing and Information, University of Pittsburgh, Pittsburgh, PA 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1357-2725(03)00242-5","article-title":"The mesothelial cell","volume":"36","author":"Mutsaers","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: Scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/rg.241035058","article-title":"Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET","volume":"24","author":"Wang","year":"2004","journal-title":"Radiographics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.21037\/jtd.2018.01.152","article-title":"Malignant pleural mesothelioma: Some progress, but still a long way from cure","volume":"10","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/cas.12698","article-title":"Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells","volume":"106","author":"Hakiri","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","article-title":"Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma","volume":"84","author":"Zauderer","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2013.11.011","article-title":"Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma","volume":"84","author":"Zucali","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/path.3979","article-title":"BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma","volume":"227","author":"Busacca","year":"2012","journal-title":"J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10147-013-0619-5","article-title":"Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy","volume":"19","author":"Toyokawa","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2015.04.013","article-title":"Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders","volume":"161","author":"Sahni","year":"2015","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2014.10.050","article-title":"A Proteome-Scale Map of the Human Interactome Network","volume":"159","author":"Rolland","year":"2014","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/npjschz.2016.12","article-title":"Schizophrenia interactome with 504 novel protein\u2013protein interactions","volume":"2","author":"Ganapathiraju","year":"2016","journal-title":"Npj Schizophr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.immuni.2014.05.007","article-title":"Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor","volume":"40","author":"Zhu","year":"2014","journal-title":"Immunity"},{"key":"ref_18","first-page":"520","article-title":"Global genetic analysis in mice unveils central role for cilia in congenital heart disease","volume":"521","author":"Li","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/ng.3870","article-title":"The complex genetics of hypoplastic left heart syndrome","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48307-w","article-title":"Potentially repurposable drugs for schizophrenia identified from its interactome","volume":"9","author":"Karunakaran","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN\u2013PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","volume":"77","author":"Montero","year":"2012","journal-title":"Lung Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human Protein Reference Database\u20142009 update","volume":"37","author":"Prasad","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: A general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Karunakaran, K.B., Yanamala, N., Boyce, G., and Ganapathiraju, M.K. (2018). Mesothelioma Interactome with 367 Novel Protein-Protein Interactions. bioRxiv, 459065.","DOI":"10.1101\/459065"},{"key":"ref_25","first-page":"146","article-title":"ReactomeFIViz: A Cytoscape app for pathway and network-based data analysis","volume":"3","author":"Wu","year":"2014","journal-title":"F1000Research"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Orii, N., and Ganapathiraju, M.K. (2012). Wiki-Pi: A Web-Server of Annotated Human Protein-Protein Interactions to Aid in Discovery of Protein Function. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049029"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/765748","article-title":"National Mesothelioma Virtual Bank: A Platform for Collaborative Research and Mesothelioma Biobanking Resource to Support Translational Research","volume":"2013","author":"Amin","year":"2013","journal-title":"Lung Cancer Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2153-3539.68314","article-title":"A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research","volume":"1","author":"Amin","year":"2010","journal-title":"J. Pathol. Inform."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Green","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/CAD.0b013e3280cc2c6f","article-title":"Targeting Akt in cancer therapy","volume":"18","author":"LoPiccolo","year":"2007","journal-title":"Anti-Cancer Drugs"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kupershmidt, I., Su, Q.J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Shekar, M., Wang, H., Park, J., and Cui, W. (2010). Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013066"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chattopadhyay, A., and Ganapathiraju, M.K. (2017). Demonstration Study: A Protocol to Combine Online Tools and Databases for Identifying Potentially Repurposable Drugs. Data, 2.","DOI":"10.3390\/data2020015"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","article-title":"Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications","volume":"25","author":"Suraokar","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","article-title":"Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling","volume":"166","author":"Gordon","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1165\/rcmb.2009-0206TR","article-title":"Asbestos, lung cancers, and mesotheliomas: From molecular approaches to targeting tumor survival pathways","volume":"42","author":"Heintz","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: A knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nuc. Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/bjc.2016.281","article-title":"A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy","volume":"115","author":"Kotsakis","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1200\/JCO.2010.30.5474","article-title":"Phase II Study of Dasatinib in Patients with Advanced Non\u2013Small-Cell Lung Cancer","volume":"28","author":"Johnson","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtho.2017.10.033","article-title":"Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma","volume":"13","author":"Tsao","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002512-200017010-00004","article-title":"Docetaxel. A review of its use in non-small cell lung cancer","volume":"17","author":"Comer","year":"2000","journal-title":"Drugs Aging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CLC.2004.n.020","article-title":"Docetaxel for malignant mesothelioma: Phase II study of the Eastern Cooperative Oncology Group","volume":"6","author":"Belani","year":"2004","journal-title":"Clin. Lung Cancer"},{"key":"ref_42","first-page":"3441","article-title":"Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: A single institution phase II study","volume":"29","author":"Ralli","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COC.0b013e3181cae90e","article-title":"Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: A single institution study","volume":"34","author":"Tourkantonis","year":"2011","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14737140.4.3.345","article-title":"Gemcitabine (Gemzar\u00ae) in non-small cell lung cancer","volume":"4","author":"Manegold","year":"2004","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/sonc.2002.30232","article-title":"The role of gemcitabine in the treatment of malignant mesothelioma","volume":"29","author":"Kindler","year":"2002","journal-title":"Semin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/tlcr.2017.03.01","article-title":"Current state of immunotherapy for non-small cell lung cancer","volume":"6","author":"Malhotra","year":"2007","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"LBA8507","DOI":"10.1200\/JCO.2017.35.18_suppl.LBA8507","article-title":"Second-or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial","volume":"35","author":"Scherpereel","year":"2017","journal-title":"Am. Soc. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2012.06.008","article-title":"Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer","volume":"78","author":"Spigel","year":"2012","journal-title":"Lung Cancer"},{"key":"ref_49","first-page":"505","article-title":"Ixabepilone: A new chemotherapeutic option for refractory metastatic breast cancer","volume":"2","author":"Puhalla","year":"2008","journal-title":"Biol. Targets Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1200\/JCO.2009.23.9749","article-title":"Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients with Stage I\/II Resectable Non\u2013Small-Cell Lung Cancer","volume":"28","author":"Altorki","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jare.2014.11.012","article-title":"Mesothelioma treatment: Are we on target? A review","volume":"6","author":"Hiddinga","year":"2015","journal-title":"J. Adv. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III Study Comparing Cisplatin Plus Gemcitabine with Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients with Advanced-Stage Non\u2013Small-Cell Lung Cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III Study of Pemetrexed in Combination with Cisplatin Versus Cisplatin Alone in Patients with Malignant Pleural Mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/LCTT.S135802","article-title":"A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma","volume":"8","author":"Jamil","year":"2017","journal-title":"Lung Cancer Targets Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/JTO.0b013e31824c7d43","article-title":"Zoledronic Acid Produces Antitumor Effects on Mesothelioma Through Apoptosis and S-Phase Arrest in p53-Independent and Ras prenylation-Independent Manners","volume":"7","author":"Okamoto","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtcvs.2009.06.027","article-title":"Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma","volume":"139","author":"Hartman","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.20062","article-title":"A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: A future drug against a fatal neoplastic disease?","volume":"109","author":"Tomasetti","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1179\/1351000213Y.0000000064","article-title":"Mitochondrial targeting of \u03b1-tocopheryl succinate enhances its anti-mesothelioma efficacy","volume":"19","author":"Kovarova","year":"2014","journal-title":"Redox Rep."},{"key":"ref_59","first-page":"38","article-title":"The evidence to date: A redox-inactive analogue of tocotrienol as a new anti-mesothelioma agent","volume":"2","author":"Sato","year":"2016","journal-title":"J. Rare Dis. Res. Treat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/onc.2010.456","article-title":"Keratins in health and cancer: More than mere epithelial cell markers","volume":"30","author":"Karantza","year":"2010","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"R\u00f8e, O.D., Szulkin, A., Anderssen, E., Flatberg, A., Sandeck, H., Amundsen, T., Erlandsen, S.E., Dobra, K., and Sundstr\u00f8m, S.H. (2012). Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040521"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","article-title":"Calretinin and other mesothelioma markers in synovial sarcoma: Analysis of antigenic similarities and differences with malignant mesothelioma","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.21873\/anticanres.11171","article-title":"Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells","volume":"36","author":"Choi","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2007.04.030","article-title":"Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization","volume":"43","author":"Kimura","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/JTO.0b013e3181d2f008","article-title":"Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma","volume":"5","author":"Yasumitsu","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rmed.2010.10.010","article-title":"Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma","volume":"105","author":"Hirayama","year":"2011","journal-title":"Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1634\/theoncologist.2013-0177","article-title":"Effects of Sulfonylureas on Tumor Growth: A Review of the Literature","volume":"18","author":"Pasello","year":"2013","journal-title":"Oncologist"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.JTO.0000263715.84567.5f","article-title":"Phase II Trial of Pralatrexate (10-Propargyl-10-deazaaminopterin, PDX) in Patients with Unresectable Malignant Pleural Mesothelioma","volume":"2","author":"Krug","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/0008-5472.CAN-09-1073","article-title":"Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"69565","DOI":"10.18632\/oncotarget.11829","article-title":"Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1541-7786.MCR-14-0038","article-title":"Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma","volume":"12","author":"Marek","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ccr.2011.07.011","article-title":"Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers","volume":"20","author":"Wilson","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2559.2003.01568.x","article-title":"Over-expression of tenascin-C in malignant pleural mesothelioma","volume":"42","author":"Soini","year":"2003","journal-title":"Histopathology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1183\/09031936.00015710","article-title":"Malignant pleural effusion cells show aberrant glucose metabolism gene expression","volume":"37","author":"Lin","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Crispi, S., Calogero, R.A., Santini, M., Mellone, P., Vincenzi, B., Citro, G., Vicidomini, G., Fasano, S., Meccariello, R., and Cobellis, G. (2009). Global Gene Expression Profiling of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007016"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1158\/1078-0432.CCR-12-2117","article-title":"Sequential Binary Gene Ratio Tests Define a Novel Molecular Diagnostic Strategy for Malignant Pleural Mesothelioma","volume":"19","author":"Richards","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans","volume":"348","author":"Consortium","year":"2015","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/15287394.2017.1408201","article-title":"Characterization of pulmonary responses in mice to asbestos\/asbestiform fibers using gene expression profiles","volume":"81","author":"Yanamala","year":"2017","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/08958370591002030","article-title":"A Review of the Toxicology and Epidemiology of Wollastonite","volume":"17","author":"Maxim","year":"2005","journal-title":"Inhal. Toxicol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Zhang","year":"2017","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2006.02.009","article-title":"Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer","volume":"53","author":"Seto","year":"2006","journal-title":"Lung Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"32643","DOI":"10.1038\/srep32643","article-title":"Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo","volume":"6","author":"Greening","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"srep44829","DOI":"10.1038\/srep44829","article-title":"Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics","volume":"7","author":"Bracht","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_86","first-page":"201","article-title":"Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited","volume":"1846","author":"Lupo","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_87","unstructured":"Nasu, M. (2012). Identification of bap1 as a Predisposing Gene for Malignant Mesothelioma, University of Hawaii."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1007\/s13277-014-1938-5","article-title":"Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma","volume":"35","author":"Yao","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study","volume":"10","author":"Iacono","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijbiomac.2017.05.093","article-title":"Codonopsis lanceolata polysaccharide CLPS inhibits melanoma metastasis via regulating integrin signaling","volume":"103","author":"Liu","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Okamoto, T., Iwata, S., Yamazaki, H., Hatano, R., Komiya, E., Dang, N.H., Ohnuma, K., and Morimoto, C. (2014). CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086671"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4049\/jimmunol.171.3.1319","article-title":"The Lyn Tyrosine Kinase Negatively Regulates Neutrophil Integrin Signaling","volume":"171","author":"Pereira","year":"2003","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","article-title":"A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin","volume":"26","author":"Orlova","year":"2007","journal-title":"EMBO J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1074\/jbc.M109068200","article-title":"Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with \u03b21 Integrin and Phosphatidylinositol 3-Kinase-dependent PKC\u03b1 Activation","volume":"277","author":"Podar","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1159\/000510534","article-title":"Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis","volume":"43","author":"Zhang","year":"2020","journal-title":"Oncol. Res. Treat."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1165\/rcmb.2014-0038OC","article-title":"Asbestos-Induced Pulmonary Fibrosis Is Augmented in 8-Oxoguanine DNA Glycosylase Knockout Mice","volume":"52","author":"Cheresh","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_97","first-page":"326","article-title":"A murine model of asbestosis","volume":"112","author":"Bozelka","year":"1983","journal-title":"Am. J. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","article-title":"A Mouse Model Recapitulating Molecular Features of Human Mesothelioma","volume":"65","author":"Altomare","year":"2005","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrg.2017.19","article-title":"Comparative transcriptomics in human and mouse","volume":"18","author":"Breschi","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Thahir, M., Sharma, T., and Ganapathiraju, M.K. (2012). An efficient heuristic method for active feature acquisition and its application to protein-protein interaction prediction. BMC Proc., 6.","DOI":"10.1186\/1753-6561-6-S7-S2"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2013","journal-title":"Genome Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cgt.2013.1","article-title":"Gene therapy for malignant mesothelioma: Current prospects and challenges","volume":"20","author":"Tagawa","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"ref_104","first-page":"4589","article-title":"Association between expression of thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase and efficacy of pemetrexed in advanced non-small cell lung cancer","volume":"32","author":"Shimizu","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/0008-5472.CAN-08-0222","article-title":"Pyrimethamine Induces Apoptosis of Melanoma Cells via a Caspase and Cathepsin Double-Edged Mechanism","volume":"68","author":"Giammarioli","year":"2008","journal-title":"Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00262-017-2057-0","article-title":"The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer","volume":"67","author":"Khan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jama.1977.03270310036004","article-title":"Sulfamethoxazole-Trimethoprim for Infections in Cancer Patients","volume":"237","author":"Grose","year":"1977","journal-title":"JAMA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/clinids\/4.2.579","article-title":"Use of Trimethoprim-Sulfamethoxazole for Treatment of Infections in Patients with Cancer","volume":"4","author":"Bodey","year":"1982","journal-title":"Clin. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/15384047.2016.1141839","article-title":"Identifying cancer origin using circulating tumor cells","volume":"17","author":"Lu","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1309\/DT6BJ698LDX2NGGX","article-title":"Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel","volume":"125","author":"Nitadori","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.humpath.2005.12.019","article-title":"Expression of p63, keratin 5\/6, keratin 7, and surfactant-A in non\u2013small cell lung carcinomas","volume":"37","author":"Camilo","year":"2006","journal-title":"Hum. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/00000478-199810000-00006","article-title":"Value of cytokeratin 5\/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma","volume":"22","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-5173(03)00140-6","article-title":"Binding of primaquine to epidermal membranes and keratin","volume":"257","author":"Heard","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.febslet.2014.08.011","article-title":"The antimalarial drugs chloroquine and primaquine inhibit pyridoxal kinase, an essential enzyme for vitamin B6 production","volume":"588","author":"Kimura","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamem.2010.08.009","article-title":"Effects of the antimalarial drug primaquine on the dynamic structure of lipid model membranes","volume":"1808","author":"Basso","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_116","unstructured":"Gakhar, G., Ohira, T., Battina, S., Hua, D.H., and Nguyen, T.A. (2007, January 14\u201318). Anti-Tumor Effect of Primaquine Compounds in Human Breast Cancer Cells. Proceedings of the AACR Annual Meeting, Las Angeles, CA, USA."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/JTO.0000000000000360","article-title":"SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)","volume":"10","author":"Ou","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1056-8727(01)00229-X","article-title":"Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells: Inhibitory effect of gliclazide","volume":"16","author":"Mamputu","year":"2002","journal-title":"J. Diabetes Complicat."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/7\/1660\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:06Z","timestamp":1760363886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/7\/1660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":118,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cancers13071660"],"URL":"https:\/\/doi.org\/10.3390\/cancers13071660","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}